We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05067283
Brief Title: A Study of MK-1084 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With KRASG12C Mutant Advanced Solid Tumors (MK-1084-001)

First Submitted : October 1, 2021
First Submitted that Met QC Criteria : October 1, 2021
First Posted : October 5, 2021

Last Update Submitted that Met QC Criteria : September 28, 2022
Last Update Posted : September 29, 2022